Insulet | PODD - Ebitda

金融业

USD 150.03

USD 3.42B

现金及等价物

USD 584.4M

USD 209.9M

USD 2.04B

USD 814.4M

USD 962.1M

USD 189.8M

USD 233.7M

3.9K

EPS每股收益

USD 1.99

股本和储备

USD 1.58B

USD 632.1M

债务利息支出

USD 12.3M

USD 3.6M

USD 943M

USD 10.35B

USD 141.1M

USD 652.2M

USD 189.8M

普通股股本

USD 69.37M

21.28

USD 177.2M

USD 842M

销售和管理费用

USD 350.7M

USD 552.1M

贸易债权人

USD 162.2M

应收帐款人

USD 689M

	Ebitda	更改		日
Abbott	USD 2.43B		844M	2026-03
Align Technology	USD 232.86M		3.72M	2026-06
AtriCure	USD 26.8M		480K	2026-09
Baxter International	USD 474M		165M	2026-06
Becton, Dickinson and Co.	USD 1.71B		1B	2026-06
Boston Scientific	USD 1.63B		27M	2026-06
Cardinal Health	USD 955M		135M	2026-06
Cooper Companies	USD 67.9M		255.5M	2026-03
Dexcom	USD 435.2M		46.5M	2026-09
Edwards Lifesciences	USD 562.2M		6.6M	2026-06
Eli Lilly	USD 9.46B		3.54B	2026-09
Globus Medical	USD 262.21M		17.63M	2026-09
ICU Medical	USD 113.91M		3.88M	2026-09
Insulet	USD 233.7M		33.9M	2026-09
Integra LifeSciences	USD 79.79M		1.37M	2026-09
J&J	USD 8.99B		721M	2026-06
Medtronic	USD 2.63B		174M	2026-06
Merit Medical Systems	USD 103.93M		461K	2026-09
Roche Holding	CHF 13.43B		744M	2026-06
Solventum Corp	USD 523M		147M	2026-09
Stryker	USD 1.83B		102M	2026-09
Tandem Diabetes Care	USD 18.04M		11.62M	2026-09
Teleflex	USD 122.91M		47.28M	2026-06
West Pharmaceutical Services	USD 267.4M		23.8M	2026-09
Zimmer Biomet Holdings	USD 634.8M		195.7M	2026-09